Multiplex assay ready: PBS only formulation, ready for custom conjugation.
Summary
Specifications
Antibody Isotype
IgG
Clone
9D5
Species Reactivity
D. melanogaster
Immunogen
Drosophila melanogaster Dopamine transporter
Conjugate
Unconjugated
Applications
Application Notes
Suitable for use in IF. Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
General Notes
Recombinant monoclonal antibody to D. melanogaster DAT. Produced utilizing a recombinant platform technology. It can be used in IF.
Target
Alternative Names
dopamine transporter; DAT; SLC6A3; DAT1; PKDYS
Citations
Publication ()
Have you cited DMAB-CDB25403 in a publication? Let us know and earn a reward for your research.
My Review for Hi-Puri™ Rabbit Anti-D. melanogaster DAT Monoclonal antibody, clone 9D5
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
References
X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.
Most antidepressants elicit their therapeutic benefits through selective blockade of Na(+)/Cl(-)-coupled neurotransmitter transporters. Here we report X-ray structures of the Drosophila melanogaster dopamine transporter in complexes with the polycyclic antidepressants nisoxetine or reboxetine. The inhibitors stabilize the transporter in an outward-open conformation by occupying the substrate-binding site. These structures explain how interactions between the binding pocket and substituents on the aromatic rings of antidepressants modulate drug-transporter selectivity.